Tin tức & Cập nhật
Lọc theo Chuyên ngành:
TTFields a new treatment paradigm for unresectable pancreatic cancer?
Tumour treating fields (TTFields) added to first-line chemotherapy (gemcitabine and nab-paclitaxel [GnP]) extends survival in individuals with locally advanced pancreatic adenocarcinoma (LA-PAC) in the PANOVA-3 study.
TTFields a new treatment paradigm for unresectable pancreatic cancer?
1 giờ trước
AMPLITUDE: Niraparib plus AAP improves survival in mCSPC patients with gene mutations
The combination of niraparib (NIRA) and abiraterone acetate plus prednisone (AAP) results in significant improvements in radiographic progression-free survival (rPFS) and time to symptomatic progression (TSP) in metastatic castration-sensitive prostate cancer (mCSPC) patients with alterations in homologous recombination repair (HRR) genes, as shown by the results of the phase III AMPLITUDE trial.
AMPLITUDE: Niraparib plus AAP improves survival in mCSPC patients with gene mutations
một ngày trước
Two-drug combo rises to the challenge as 1L Tx for mTNBC
In the primary analysis of the ASCENT-04/KEYNOTE-D19 study, a combination regimen comprising sacituzumab govitecan (SG) and pembrolizumab delivers significant progression-free survival (PFS) benefit in women with previously untreated PD-L1+ advanced triple-negative breast cancer (TNBC).
Two-drug combo rises to the challenge as 1L Tx for mTNBC
02 Jul 2025
Add-on olanzapine prevents RT-induced nausea, vomiting
In patients undergoing abdominal-pelvic radiation therapy (RT), treatment with olanzapine along with an antiemetic medication leads to a substantial decrease in RT-induced nausea and vomiting (RINV), with no serious adverse effects, reports a study presented at ASCO 2025.
